Auto-Injectors Market: Rapidly Evolving Industry…… COVID-19….



The global auto-injectors market size is expected to reach USD 3.18 billion by 2026, according to a new report by Grand View Research, Inc, exhibiting a CAGR of 19.5%. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth.
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions.
In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.
Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and user-friendly. This is encouraging patients to adopt this technology for chronic illnesses.
To Request Sample Copy of this report, click the link:
https://www.grandviewresearch.com/industry-analysis/auto-injectors-market/request/rs1
Further key findings from the report suggest:
·         Disposable auto-injectors emerged as the largest segment owing to convenience and ease of use
·         Homecare settings accounted for largest share in end-use segment owing to increasing demand of products for daily administration of insulin
·         North America dominated the auto-injectors market with largest share in 2018. Increasing demand for new technologies along with advanced healthcare infrastructure is expected to boost market growth during the forecast period
·         Asia Pacific is expected to witness fastest growth during the forecast period owing to increasing number of diabetic patients
·         Some of the key players are Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Amgen; Owen Mumford; Ypsomed; Teva Pharmaceutical; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi
The global auto-injectors market size was estimated at USD 767.7 million in 2018 and is anticipated to exhibit a CAGR of 19.5%. Increase in prevalence of anaphylactic shock, rise in awareness about these devices and preferences of patients to choose self-administration of injections are the key factors propelling the overall market.
Auto-injectors are preferred over conventional devices as they enable efficient and improved drug delivery as well as new formulations. Technological advancements in products are anticipated to boost growth. For instance, Humira by AbbVie, Inc. comes with lock function and injection start & end alerts.    
Auto-injectors offer various advantages such as they reduce phobia anxiety associated to needles, reduce chances of needle stick injuries, maintain consistency of dose accuracy, and help with better efficacy, which, in turn, aid growth. Drug delivery from an auto-injector is more controlled compared to manual injection.
The injecting site of a particular drug is chosen based on nature of the drug, but it is normally administered intramuscularly. Auto-injectors are less painful compared to syringes, which increases their demand. However, availability of alternatives such as oral tablets may hinder growth.
Innovations in device functions are also anticipated to support growth. For instance, in September 2015, Bayer HealthCare launched an electronic auto-injector used to treat relapsing-remitting multiple sclerosis, which offers complete dosage of the drug for improved compliance & potentially reduces the overall cost. The SHL group offers various types of auto-injectors with large volumes and high viscosity.
Browse Press Release of this report:
https://www.grandviewresearch.com/press-release/global-auto-injectors-market
Grand View Research has segmented the global auto-injectors market based on product type, disease indication, end use:
Auto-injectors Product Type Outlook (Revenue, USD Million, 2015 - 2026)
·         Disposable Auto-Injectors
·         Reusable Auto-Injectors
o    Prefilled Auto-Injectors
o    Empty Auto-Injectors
Auto-injectors Disease Indication Outlook (Revenue, USD Million, 2015 - 2026)
·         Rheumatoid Arthritis
·         Multiple Sclerosis
·         Diabetes
·         Anaphylaxis
·         Other Therapies
Auto-injectors End-use Outlook (Revenue, USD Million, 2015 - 2026)
·         Homecare Settings
·         Hospitals & Clinics
·         Ambulatory Surgical Centers
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.





Comments

Post a Comment

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

Image
The global foot orthotic insoles market size is expected to reach USD 5.5 billion by 2026 , according to a new report by Grand View Research, Inc., exhibiting a 6.3% CAGR during the forecast period. Growing incidence of diabetes and plantar fasciitis are expected to drive the market over the forecast period. Moreover, rapid urbanization and increasing disposable income are anticipated to propel growth in future. Technological advancements, spurred by ongoing investments in R&D, are expected to increase growth potential in the coming years. Moreover, rise in geriatric population, which is susceptible to orthopedic disorders, is impelling product demand globally. For instance, in 2017 as per the U.S. Census Bureau, the number of people aged 65 or older increased by 1.6 million from 2014 to 2015. In addition, increasing incidence of sports injuries and rising prevalence of osteosarcoma in the region has led to the need for various orthotics devices, which is expected to drive ...
Read more

A Look into Smokehouse Industry……Deep Analysis…..

Image
The global smokehouse market size is anticipated to reach USD 157.2 million by 2025 , according to a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 2.2% during the forecast period. Rising need for a healthy lifestyle has led consumers to prefer griller or barbequed food over fried food and other kinds of fast food. This trend is expected to have a positive impact on the market growth. The home care & decor industry has been witnessing inconsistent growth, since the Covid 19 outbreak. As a result of the ongoing pandemic crisis, there has been a drop in the overall performance of discretionary products such as decorative fixtures, bedding products, to name a few. The virus outbreak has, however, led to substantial growth in categories such as cleaning and hygiene products. Prominent growth in the e-commerce business is also one of the positive influences of the outbreak, wherein companies are focusing on expanding their distribution ...
Read more

A Look into Shapewear Industry……Deep Analysis…..

Image
The global shapewear market size is expected to reach USD 3.80 billion by 2025 registering a CAGR of 7.7%, according to a new report by Grand View Research, Inc. The introduction of various products according to the type of garments is expected to support the market growth in the years to come. Growing target population across the globe is also augmenting the market growth. Changing lifestyle incurs increased investment in fitness and related accessories, which has positively impacted the market growth. The clothing, footwear, & accessories industry is anticipated to witness checkered growth throughout 2020, as a result of the unprecedented supply chain disruptions caused by the COVID-19 outbreak worldwide. The expected decline in the global sales of clothing, footwear, & accessories is attributable to massive supply chain disruptions across significant export markets, including China and India. However, the industry is likely to recover over the forecast timeframe,...
Read more